Cybin to Begin Phase 3 Trial of Treatment for Major Depressive Disorder This Summer Cybin (CYBN) Tuesday said it expects to begin phase 3 testing of its CYB003 drug candidate to treat major depressive...
Source LinkCybin to Begin Phase 3 Trial of Treatment for Major Depressive Disorder This Summer Cybin (CYBN) Tuesday said it expects to begin phase 3 testing of its CYB003 drug candidate to treat major depressive...
Source Link
Comments